MALAT1 and metabolic dysfunction-associated steatohepatitis: authors focused on the correlation between MALAT1 and diabetes-related complications (including cerebral ischemic reperfusion injury, diabetic retinopathy, diabetic cataract, atherosclerosis, diabetic cataract, diabetic cardiomyopathy, nonalcoholic steatohepatitis, diabetic gastropathy, diabetic kidney disease and gestational DM) and highlighted that MALAT1 is a promising diagnostic and therapeutic target for these conditions [21].